Sterling elects corporate VPs
Edward Albright to VP-corporate services with responsibility for manufacturing, engineering and management information systems; George Doherty to VP-pharmaceutical products with responsibility for drug acquisitions and divestitures; R. Kyle Greer to VP-human resources; and Raymond Hannigan to VP and area president-Sterling International. VP-Finance George Benjamin named chief financial officer.
You may also be interested in...
Court finds US FDA did not impede Catalyst orphan exclusivity for Firdapse as it approved different indication for competing product. Biogen loses 10-year patent battle against competing multiple sclerosis drug makers.
Cover Three Nutritional Brain Defense marketer agrees to pull claims suggesting the supplement beverage can protect against traumatic brain injury after a test the firm on DHA submitted as support contained considerably higher levels of the ingredient than included in the product.
The top-line data in the ultra-rare disease are also the first to demonstrate safety and efficacy of an RNAi therapy in patients six years and younger.